Middle East & Africa Biologics Market to 2031 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East & Africa Biologics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East & Africa Biologics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Preference for Outsourcing Manufacturing Operations

5.2 Market Opportunities

5.2.1 Gene and Cell Therapy Advancements in Biologics

5.3 Future Trends

5.3.1 Strategic Initiatives by Companies

5.4 Impact of Drivers and Restraints

6. Middle East & Africa Biologics Market Regional Analysis

6.1 Middle East & Africa Biologics Market Overview

6.2 Middle East & Africa Biologics Market Revenue 2025-2023 (US$ Million)

6.3 Middle East & Africa Biologics Market Forecast Analysis

7. Middle East & Africa Biologics Market Analysis – by Product

7.1 Monoclonal Antibodies

7.1.1 Overview
7.1.2 Monoclonal Antibodies: Middle East & Africa Biologics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Vaccine

7.2.1 Overview
7.2.2 Vaccine: Middle East & Africa Biologics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Recombinant Hormones/Proteins

7.3.1 Overview
7.3.2 Recombinant Hormones/Proteins: Middle East & Africa Biologics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Cell and Gene Therapy

7.4.1 Overview
7.4.2 Cell and Gene Therapy: Middle East & Africa Biologics Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Others

7.5.1 Overview
7.5.2 Others: Middle East & Africa Biologics Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Biologics Market Analysis – by Application

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

8.2 Infectious Diseases

8.2.1 Overview
8.2.2 Infectious Diseases: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

8.3 Autoimmune Diseases

8.3.1 Overview
8.3.2 Autoimmune Diseases: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

8.4 Others

8.4.1 Overview
8.4.2 Others: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

9. Middle East & Africa Biologics Market Analysis – by Source

9.1 Mammalian and Microbial

9.1.1 Overview
9.1.2 Others: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

10. Middle East & Africa Biologics Market – Middle East & Africa Analysis

10.1 Middle East & Africa

10.1.1 Middle East & Africa Biologics Market Breakdown, by Key Country, 2021 and 2023 (%)
10.1.1.1 Middle East & Africa Biologics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Saudi Arabia: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

10.1.1.1.1 Saudi Arabia: Middle East & Africa Biologics Market Breakdown, by Product
10.1.1.1.2 Saudi Arabia: Middle East & Africa Biologics Market Breakdown, by Application
10.1.1.1.3 Saudi Arabia: Middle East & Africa Biologics Market Breakdown, by Source

10.1.1.2 the UAE: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

10.1.1.2.1 the UAE: Middle East & Africa Biologics Market Breakdown, by Product
10.1.1.2.2 the UAE: Middle East & Africa Biologics Market Breakdown, by Application
10.1.1.2.3 the UAE: Middle East & Africa Biologics Market Breakdown, by Source

10.1.1.3 South Africa: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

10.1.1.3.1 South Africa: Middle East & Africa Biologics Market Breakdown, by Product
10.1.1.3.2 South Africa: Middle East & Africa Biologics Market Breakdown, by Application
10.1.1.3.3 South Africa: Middle East & Africa Biologics Market Breakdown, by Source

10.1.1.4 Rest of Middle East & Africa: Middle East & Africa Biologics Market – Revenue and Forecast to 2023 (US$ Million)

10.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa Biologics Market Breakdown, by Product
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Biologics Market Breakdown, by Application
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Biologics Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East & Africa Biologics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Pfizer Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Samsung Biologics Co Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 ADMA Biologics, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Wuxi Biologics Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Catalent Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 AGC Biologics AS

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 AstraZeneca Plc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Amgen Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Nitto Avecia

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Quality Assistance s.a.

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights